Bristol Myers Squibb Ends China Joint Venture
Update: 2025-09-17
Description
Bristol Myers Squibb exits its 40-year China joint venture, a landmark US-China pharmaceutical partnership, amid supply chain woes and pricing pressures, signaling a broader retreat of foreign pharma companies from the Chinese market.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
